Is customization available for this product?

Yes, full customization is available from designs and samples, and ODM services are supported.

What is the minimum order quantity?

The minimum order quantity is 1000 pieces.

High-Quality GMP Diclofenac and Paracetamol Pain Management Tablets

Name: High-Quality GMP Diclofenac and Paracetamol Pain Management Tablets
Brand: Anhui Medipharm Co., Ltd.
SKU: 1941667751

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$0.10

10,000 boxes

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For oral administration

Model NO.

AMC12035-01

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Tablet

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Deliver Time

30-40days

Transport Package

10′ S/Box

Specification

550mg

Trademark

MEDIPHARM/SHINEPHARM

Origin

China

HS Code

3004909099

Production Capacity

1000000 Pieces/Day

Key features

Broad Pain Management Indications: Effective for dysmenorrhea, rheumatic conditions, arthritis, dental pain, and fever associated with inflammation.

Comprehensive Safety Warnings: Includes strict contraindications for liver/kidney disease, peptic ulcers, and aspirin-sensitive patients.

Flexible Customization Options: Offers full customization from designs and samples, including ODM services.

Established Global Export Experience: 14 years of export history with 80-100% repeat buyer rate and 12 supply chain partners.

ISO Management System Certified: Certified under ISO45001:2018 and ISO14001 for safety and environmental management.

Diverse Product Portfolio: Specializes in medicine, veterinary drugs, nutritional supplements, and medical devices.

Flexible Payment and Shipping Terms: Accepts T/T, LC, D/P with FOB, CIF, and EXW international commercial terms.

Consistent Lead Time Performance: Maintains a one-month lead time during both peak and off-peak seasons.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.79h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.

Product Q&A

Q:What are the main indications for these tablets?

They are indicated for primary dysmenorrhea, non-articular rheumatic conditions, rheumatoid or osteo arthritis, cervical spondylosis, infective inflammation, dental conditions, pain, and fever associated with inflammation.

Q:Who should avoid taking this medication?

Patients with sensitivity to paracetamol, severe liver function impairment, peptic ulceration, or those who react to aspirin with asthma or urticaria should not use it. Use with caution in renal or hepatic disease.

Q:What is the recommended dosage for adults?

The usual adult dose is 1 tablet every 8 or 12 hours, or as directed by a physician. The recommended daily maximum is 3 tablets.

Q:How long can I use this product continuously?

Do not use continuously for more than 10 days without consulting your doctor. Prolonged excessive use may cause irreversible kidney damage.

Q:What are the possible adverse effects?

Occasional skin rashes, allergic reactions, drug fever, mucosal lesions, neutropenia, thrombocytopenia, pancytopenia, and leukopenia may occur.